Evidence of Phytoalexins in Rhizome of Atractylodis Maceocephalae Koidz Infected with Sclerotium rolfsii sacc Following Treatment with the Polysaccharides of Chrysanthemum indicum

Atractylenolides compounds (atractylenolide‐I, atractylenolide‐II and atractylenolide‐III) extracted from Atractylenolides macrocephala were analysed for their differential presence in the rhizome of both the infected and healthy plants and its fungitoxicity on prophylactic treatment with polysaccharides of Chrysanthemum indicum against Sclerotium rolfsii. It was evident that the plant under stress by pathogen has instigated the significant synthesis and accumulation of atractylenolide‐II and atractylenolide‐III in the rhizome of plants as a result of elicitation with polysaccharides of C. indicum. Our results also showed that the absence of atractylenolide‐II in the rhizome made the plant susceptible to S. rolfsii. Furthermore, on in vitro antifungal studies, exogenous application of atractylenolide‐II with the concentration of 200 μg/ml showed a significant inhibitory effect on mycelial growth by achieving a 77.23% antifungal activity rate, and a minimal inhibitory effect at a concentration of 12.5 μg/ml with atractylenolide‐II. To our knowledge, this novel study on phytoalexins in A. macrocephala suggested that A. macrocephala plants produce elevated levels of atractylenolide‐II and atractylenolide‐III in a pattern typical of phytoalexins, in response to an eliciting treatment after infection.     

白术多糖对小鼠免疫功能调节的研究

目的将白术多糖作为抗原刺激小鼠免疫系统,探讨其对免疫功能调节作用,为多糖在免疫调节功能方面的应用开发及在药物鉴定方面的应用提供科学依据。方法分别给予小鼠自术多糖、可溶性淀粉多糖、伤寒多糖抗原刺激,检测小鼠血清中的相应抗体及交叉抗体,探讨补益类水溶性多糖对小鼠免疫功能的调节作用。结果多糖抗原均能刺激机体产生特异性IgG类抗体（P〈0.05）;也能在一定程度上激发非特异性IgG类抗体即交叉抗体的产生;但不激发病理性抗体产生（RF阴性）。结论补益类水溶性多糖能激发免疫反应与其他多糖可能有共同的途径和机制。     

白术配伍人参前后挥发油调控慢性萎缩性胃炎大鼠AQP 3、4表达的比较研究

为探究参术药对配伍治疗慢性萎缩性胃炎的增效机制,本文就白术配伍人参前后挥发油成分物质基础变化及对慢性萎缩性胃炎大鼠胃组织水通道蛋白3(AQP 3)、水通道蛋白4(AQP 4)的影响进行了比较研究。采用水蒸气蒸馏法提取人参白术配伍前后挥发油,以GC-MS法表征挥发油化学特征,并随机将大鼠分成空白组、模型组、白术挥发油组及配伍挥发油组,使用MNNG建立慢性萎缩性胃炎模型,给药后观察各组胃黏膜组织显微、超微结构变化以及AQP 3、AQP 4的表达。结果显示,白术配伍人参后挥发油的提取量升高,经GC-MS测定,配伍后苍术酮相对含量降低,新增少量人参挥发油成分。显微及超微观察显示,模型组大鼠胃组织黏膜折叠皱起,黏膜层和固有层腺体萎缩严重,胃小凹形态改变,上皮细胞破损,炎症细胞大面积浸润,且病理评分明显高于正常组(P<0.05);各药物组与模型组相比,均缓解或改善上述病理结果,且配伍挥发油组表现更优。免疫组化结果显示,模型组大鼠胃黏膜AQP 3、AQP 4表达明显低于空白组(P<0.05);相较模型组,各药物组对胃黏膜AQP 3、AQP 4蛋白的表达有增加趋势或明显增加,且配伍挥发油组...     

毛细管气相色谱/质谱法测定关苍术中的挥发性成分

采用正己烷萃取关苍术中挥发性成分 ,以GC -MS分离 ,经计算机检索系统处理与质谱标准谱图核对 ,检出香橙烯 ([ ]-Aromadendrene)、反式石竹烯 (trans -Caryophyllene)、γ -榄香烯 (gamma -Elemene)、α -草烯(alpha -Humulene)、β -桉叶烯 (beta-Selinene)、2 -甲基苯酚 (Phenol,2 -methyl- )、石竹二烯酮 (Caryophylla - 2 [12 ],6 [13]-dien - 5 -one)、1-甲氧基 - 2 (1-甲基 - 2 -亚甲基 -环戊基 ) -苯 (Benzene,1-methoxy - 2 [1-methyl- 2 -methylenecyclopentyl]- )、呋喃 - 2 -亚甲基 - (1H -嘌呤 - 6基 ) -胺 (1H -Purin - 6 -ammine,N - [2 -furanylmethyl]- )、白术内酯 (Butenolide)、1-溴 - 8十七炔 (8-Heptadecyne ,1-beome)等 11种挥发性成分     

苍术体外抑菌活性的初步研究

对苍术的体外抑菌活性进行初步的研究。通过用体积分数为50％乙醇浸泡、有机溶剂萃取、薄层层析对苍术抑菌活性物质进行初步分析,用纸片法检测其抑菌活性,用琼脂稀释法测最低抑菌浓度（MIC）。结果表明：苍术提取液对金黄色葡萄球菌的抑菌作用较明显,对白色念珠菌和大肠杆菌的抑菌作用次之,其最低抑茵质量浓度分别为0．7g／mL,1．0g/mL和1．2g/mL;以正丁醇作为萃取液抑菌效果最佳,薄层层析实验结果表明,Rf值为0．76的展开点具有抑菌活性。